Zacks.com on MSN2d
Denali's ALS Study Fails to Meet Primary and Secondary EndpointsDNLI's DNL343 fails to achieve the primary and secondary endpoints, as observed from an analysis of Regimen G of the phase II ...
In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...
Jeffrey Jenkins, a 38-year-old aspiring surgeon, dedicated his life to medicine - but his world came crashing down with a ...
Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not ...
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...
This confirmation follows the Company's successful efforts to improve its balance sheet by raising new equity and reducing outstanding liabilities. As a result, NeuroSense shareholders' equity now ...
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) ...
Magnesium threonate has been shown in some animal studies to enhance cognitive function by raising magnesium ions in the ...
Neuron, Cell Press’s prestigious neuroscience journal, is publishing a special issue on aging research on January 8, 2025.
Neuron, Cell Press's prestigious neuroscience journal, is publishing a special issue on aging research on January 8, 2025. The collection of reviews ...
News Medical on MSN12h
Could autophagy enhancement slow aging and combat Alzheimer's?Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback